_id
691486afccc777a4e85d967a
Ticker
OCSAW
Name
Oculis Holding AG Warrants
Exchange
NASDAQ
Address
-
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
-
Description
Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidates in development includes OCS-01, a topical retinal candidate for diabetic macular edema; OCS-02, a topical biologic candidate for dry eye disease; and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.
Last Close
8.56
Volume
178
Current Price
11.9
Change
-0.43
Last Updated
2026-01-05T12:00:58.882Z
Image
-
Ipo Date
2023-03-03T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
20296000
Operating Income
-20296000
Interest Expense
162000
Pretax Income
-16842000
Net Income
-16855000
Eps
-0.3218150037811115
Dividends Per Share
0
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
3178000
Cash
46440000
Short Term Investments
98740000
Receivables
-
Inventories
-
Total Current Assets
150908000
Property Plant Equipment
3104000
Total Assets
167836000
Payables
1221000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
37242000
Equity
130594000
Bs_currency_symbol
CHF
Depreciation
152000
Change In Working Capital
2112000
Cash From Operations
-13418000
Capital Expenditures
124000
Cash From Investing
-
Cash From Financing
-1711000
Net Change In Cash
-17724000
Cf_currency_symbol
CHF
PE
-
PB
4.772502954959646
ROE
-12.9064122394597
ROA
-10.042541528635097
FCF
-13542000
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
2.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
20296000
Quarters > 0 > income Statement > operating Income
-20296000
Quarters > 0 > income Statement > interest Expense
162000
Quarters > 0 > income Statement > pretax Income
-16842000
Quarters > 0 > income Statement > net Income
-16855000
Quarters > 0 > income Statement > eps
-0.3218150037811115
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
52374811
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
3178000
Quarters > 0 > income Statement > currency_symbol
CHF
Quarters > 0 > balance Sheet > cash
46440000
Quarters > 0 > balance Sheet > short Term Investments
98740000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
150908000
Quarters > 0 > balance Sheet > property Plant Equipment
3104000
Quarters > 0 > balance Sheet > total Assets
167836000
Quarters > 0 > balance Sheet > payables
1221000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
37242000
Quarters > 0 > balance Sheet > equity
130594000
Quarters > 0 > balance Sheet > currency_symbol
CHF
Quarters > 0 > cash Flow > net Income
-16855000
Quarters > 0 > cash Flow > depreciation
152000
Quarters > 0 > cash Flow > change In Working Capital
2112000
Quarters > 0 > cash Flow > cash From Operations
-13418000
Quarters > 0 > cash Flow > capital Expenditures
124000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-1711000
Quarters > 0 > cash Flow > net Change In Cash
-17724000
Quarters > 0 > cash Flow > currency_symbol
CHF
Quarters > 0 > ratios > PE
-0.3218150037811115
Quarters > 0 > ratios > PB
4.772502954959646
Quarters > 0 > ratios > ROE
-12.9064122394597
Quarters > 0 > ratios > ROA
-10.042541528635097
Quarters > 0 > ratios > FCF
-13542000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
20768000
Quarters > 1 > income Statement > operating Income
-20768000
Quarters > 1 > income Statement > interest Expense
183000
Quarters > 1 > income Statement > pretax Income
-25399000
Quarters > 1 > income Statement > net Income
-25375000
Quarters > 1 > income Statement > eps
-0.4848501385066375
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
52335759
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-4968000
Quarters > 1 > income Statement > currency_symbol
CHF
Quarters > 1 > balance Sheet > cash
64265000
Quarters > 1 > balance Sheet > short Term Investments
96035000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
166200000
Quarters > 1 > balance Sheet > property Plant Equipment
1596000
Quarters > 1 > balance Sheet > total Assets
181621000
Quarters > 1 > balance Sheet > payables
1204000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
38525000
Quarters > 1 > balance Sheet > equity
143096000
Quarters > 1 > balance Sheet > currency_symbol
CHF
Quarters > 1 > cash Flow > net Income
-25375000
Quarters > 1 > cash Flow > depreciation
113000
Quarters > 1 > cash Flow > change In Working Capital
-1212000
Quarters > 1 > cash Flow > cash From Operations
-17242000
Quarters > 1 > cash Flow > capital Expenditures
126000
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
605000
Quarters > 1 > cash Flow > net Change In Cash
9144000
Quarters > 1 > cash Flow > currency_symbol
CHF
Quarters > 1 > ratios > PE
-0.4848501385066375
Quarters > 1 > ratios > PB
4.352291692989322
Quarters > 1 > ratios > ROE
-17.732850673673617
Quarters > 1 > ratios > ROA
-13.971401985453225
Quarters > 1 > ratios > FCF
-17368000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
19974000
Quarters > 2 > income Statement > operating Income
-19974000
Quarters > 2 > income Statement > interest Expense
247000
Quarters > 2 > income Statement > pretax Income
-33206000
Quarters > 2 > income Statement > net Income
-33213000
Quarters > 2 > income Statement > eps
-0.6379692857348662
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
52060500
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-13478000
Quarters > 2 > income Statement > currency_symbol
CHF
Quarters > 2 > balance Sheet > cash
59873000
Quarters > 2 > balance Sheet > short Term Investments
122055000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
188789000
Quarters > 2 > balance Sheet > property Plant Equipment
1582000
Quarters > 2 > balance Sheet > total Assets
204171000
Quarters > 2 > balance Sheet > payables
4351000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
41545000
Quarters > 2 > balance Sheet > equity
162626000
Quarters > 2 > balance Sheet > currency_symbol
CHF
Quarters > 2 > cash Flow > net Income
-33213000
Quarters > 2 > cash Flow > depreciation
123000
Quarters > 2 > cash Flow > change In Working Capital
-642000
Quarters > 2 > cash Flow > cash From Operations
-18963000
Quarters > 2 > cash Flow > capital Expenditures
1100000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
103831000
Quarters > 2 > cash Flow > net Change In Cash
33363000
Quarters > 2 > cash Flow > currency_symbol
CHF
Quarters > 2 > ratios > PE
-0.6379692857348662
Quarters > 2 > ratios > PB
3.809476651949873
Quarters > 2 > ratios > ROE
-20.42293360225302
Quarters > 2 > ratios > ROA
-16.267246572725803
Quarters > 2 > ratios > FCF
-20063000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
17260000
Quarters > 3 > income Statement > operating Income
-17260000
Quarters > 3 > income Statement > interest Expense
246000
Quarters > 3 > income Statement > pretax Income
-28893000
Quarters > 3 > income Statement > net Income
-28655000
Quarters > 3 > income Statement > eps
-0.6562854695900606
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
43662402
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-11758000
Quarters > 3 > income Statement > currency_symbol
CHF
Quarters > 3 > balance Sheet > cash
27708000
Quarters > 3 > balance Sheet > short Term Investments
70955000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
104897000
Quarters > 3 > balance Sheet > property Plant Equipment
1688000
Quarters > 3 > balance Sheet > total Assets
120353000
Quarters > 3 > balance Sheet > payables
5871000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
46970000
Quarters > 3 > balance Sheet > equity
73383000
Quarters > 3 > balance Sheet > currency_symbol
CHF
Quarters > 3 > cash Flow > net Income
-28655000
Quarters > 3 > cash Flow > depreciation
122000
Quarters > 3 > cash Flow > change In Working Capital
3189000
Quarters > 3 > cash Flow > cash From Operations
-10358000
Quarters > 3 > cash Flow > capital Expenditures
57000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2708000
Quarters > 3 > cash Flow > net Change In Cash
-8765000
Quarters > 3 > cash Flow > currency_symbol
CHF
Quarters > 3 > ratios > PE
-0.6562854695900606
Quarters > 3 > ratios > PB
7.080421675319897
Quarters > 3 > ratios > ROE
-39.048553479688756
Quarters > 3 > ratios > ROA
-23.80912814803121
Quarters > 3 > ratios > FCF
-10415000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
73204000
Annuals > 0 > income Statement > operating Income
-73204000
Annuals > 0 > income Statement > interest Expense
639000
Annuals > 0 > income Statement > pretax Income
-85937000
Annuals > 0 > income Statement > net Income
-85777000
Annuals > 0 > income Statement > eps
-1.9645506447400671
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
43662402
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-14262000
Annuals > 0 > income Statement > currency_symbol
CHF
Annuals > 0 > balance Sheet > cash
27708000
Annuals > 0 > balance Sheet > short Term Investments
70955000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
104897000
Annuals > 0 > balance Sheet > property Plant Equipment
1688000
Annuals > 0 > balance Sheet > total Assets
120353000
Annuals > 0 > balance Sheet > payables
5871000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
46970000
Annuals > 0 > balance Sheet > equity
73383000
Annuals > 0 > balance Sheet > currency_symbol
CHF
Annuals > 0 > cash Flow > net Income
-85777000
Annuals > 0 > cash Flow > depreciation
406000
Annuals > 0 > cash Flow > change In Working Capital
14161000
Annuals > 0 > cash Flow > cash From Operations
-47499000
Annuals > 0 > cash Flow > capital Expenditures
230000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
54030000
Annuals > 0 > cash Flow > net Change In Cash
-11026000
Annuals > 0 > cash Flow > currency_symbol
CHF
Annuals > 0 > ratios > PE
-1.9645506447400671
Annuals > 0 > ratios > PB
5.093143658885573
Annuals > 0 > ratios > ROE
-116.88947031328783
Annuals > 0 > ratios > ROA
-71.27117728681462
Annuals > 0 > ratios > FCF
-47729000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
25
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
45851000
Annuals > 1 > income Statement > operating Income
-45851000
Annuals > 1 > income Statement > interest Expense
1315000
Annuals > 1 > income Statement > pretax Income
-88695000
Annuals > 1 > income Statement > net Income
-88802000
Annuals > 1 > income Statement > eps
-2.4229935820765816
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
36649705
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-42958000
Annuals > 1 > income Statement > currency_symbol
CHF
Annuals > 1 > balance Sheet > cash
38327000
Annuals > 1 > balance Sheet > short Term Investments
53324000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
101015000
Annuals > 1 > balance Sheet > property Plant Equipment
1043000
Annuals > 1 > balance Sheet > total Assets
114353000
Annuals > 1 > balance Sheet > payables
7596000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
20625000
Annuals > 1 > balance Sheet > equity
93728000
Annuals > 1 > balance Sheet > currency_symbol
CHF
Annuals > 1 > cash Flow > net Income
-88802000
Annuals > 1 > cash Flow > depreciation
287000
Annuals > 1 > cash Flow > change In Working Capital
-12991000
Annuals > 1 > cash Flow > cash From Operations
-53845000
Annuals > 1 > cash Flow > capital Expenditures
48000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
129672000
Annuals > 1 > cash Flow > net Change In Cash
21616000
Annuals > 1 > cash Flow > currency_symbol
CHF
Annuals > 1 > ratios > PE
-2.4229935820765816
Annuals > 1 > ratios > PB
3.347147861898259
Annuals > 1 > ratios > ROE
-94.74436667804711
Annuals > 1 > ratios > ROA
-77.65603001233025
Annuals > 1 > ratios > FCF
-53893000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
32376000
Annuals > 2 > income Statement > operating Income
-32376000
Annuals > 2 > income Statement > interest Expense
6442000
Annuals > 2 > income Statement > pretax Income
-38643000
Annuals > 2 > income Statement > net Income
-38698000
Annuals > 2 > income Statement > eps
-1.1822185266394636
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
32733373
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-31902000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
49000
Annuals > 2 > income Statement > currency_symbol
CHF
Annuals > 2 > balance Sheet > cash
19786000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
23657000
Annuals > 2 > balance Sheet > property Plant Equipment
1123000
Annuals > 2 > balance Sheet > total Assets
37060000
Annuals > 2 > balance Sheet > payables
3867000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
122449000
Annuals > 2 > balance Sheet > total Liabilities
135051000
Annuals > 2 > balance Sheet > equity
-97991000
Annuals > 2 > balance Sheet > currency_symbol
CHF
Annuals > 2 > cash Flow > net Income
-38698000
Annuals > 2 > cash Flow > depreciation
299000
Annuals > 2 > cash Flow > change In Working Capital
5998000
Annuals > 2 > cash Flow > cash From Operations
-25074000
Annuals > 2 > cash Flow > capital Expenditures
3548000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
1714000
Annuals > 2 > cash Flow > net Change In Cash
-26909000
Annuals > 2 > cash Flow > currency_symbol
CHF
Annuals > 2 > ratios > PE
-1.1822185266394636
Annuals > 2 > ratios > PB
-2.859422527374963
Annuals > 2 > ratios > ROE
39.491381861599535
Annuals > 2 > ratios > ROA
-104.41985968699406
Annuals > 2 > ratios > FCF
-28622000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
13232000
Annuals > 3 > income Statement > operating Income
-13232000
Annuals > 3 > income Statement > interest Expense
5120000
Annuals > 3 > income Statement > pretax Income
-18524000
Annuals > 3 > income Statement > net Income
-18552000
Annuals > 3 > income Statement > eps
-0.5667610239861318
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
32733373
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-13169000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-193000
Annuals > 3 > income Statement > currency_symbol
CHF
Annuals > 3 > balance Sheet > cash
46277000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
47981000
Annuals > 3 > balance Sheet > property Plant Equipment
1287000
Annuals > 3 > balance Sheet > total Assets
58043000
Annuals > 3 > balance Sheet > payables
824000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
113502000
Annuals > 3 > balance Sheet > total Liabilities
118998000
Annuals > 3 > balance Sheet > equity
-60955000
Annuals > 3 > balance Sheet > currency_symbol
CHF
Annuals > 3 > cash Flow > net Income
-18552000
Annuals > 3 > cash Flow > depreciation
235000
Annuals > 3 > cash Flow > change In Working Capital
-791000
Annuals > 3 > cash Flow > cash From Operations
-13825000
Annuals > 3 > cash Flow > capital Expenditures
28000
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
55194000
Annuals > 3 > cash Flow > net Change In Cash
41341000
Annuals > 3 > cash Flow > currency_symbol
CHF
Annuals > 3 > ratios > PE
-0.5667610239861318
Annuals > 3 > ratios > PB
-4.5967955521286195
Annuals > 3 > ratios > ROE
30.435567221720945
Annuals > 3 > ratios > ROA
-31.962510552521405
Annuals > 3 > ratios > FCF
-13853000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.3218150037811115
Valuation > metrics > PB
4.772502954959646
Valuation > final Score
32.27497045040354
Valuation > verdict
59.1% Overvalued
Profitability > metrics > ROE
-12.9064122394597
Profitability > metrics > ROA
-11.169056643782966
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.285173897728839
Risk > metrics > Interest Coverage
-125.28395061728395
Risk > final Score
-441
Risk > verdict
High
Liquidity > metrics > Current Ratio
123.59377559377559
Liquidity > metrics > Quick Ratio
123.59377559377559
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
36.47708307010678
Prev Valuations > 1
41.90523348050127
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-394
Prev Risks > 1
-263
Prev Risks > 2
-233
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:20:02.512Z
Oculis Holding AG, a biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidates in development includes OCS-01, a topical retinal candidate for diabetic macular edema; OCS-02, a topical biologic candidate for dry eye disease; and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAug Movers: Will Stellar V Capital Corp Equity Warrant benefit from rate cuts - Market Growth Review & High Win Rate Trade Tips baoquankhu1.vn
Read more →Aug Closing: Is JanOne Inc stock a value trap - Market Trend Review & Weekly Setup with ROI Potential baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Oculis Holding AG Warrants
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.